Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's Cancer Review Staff Should All Move To Oncology Center of Excellence, Advocates Say

Mar 16 2018

• By Michael Cipriano

FDA entrance sign 2016

Related Content

RMAT Designation, Gene Therapies Highlight 2017 CBER Transformation

Jan 18 2018

US FDA May Create Immunology, Neuroscience Centers Of Excellence

Dec 02 2017

Gene Therapy Guidances Will Focus On Specific Diseases, Gottlieb Says

Dec 07 2017

Oncology In 21<sup>st</sup> Century Cures: Heading Toward A Two-FDA Solution?

Jan 10 2017

Cures Bill Authorizes 'Intercenter Institutes,' But Will US FDA Create Them?

Nov 28 2016

Related Companies

Merck & Co., Inc.

Additional Topics

United States Drug Review Regulation Cancer BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window